메뉴 건너뛰기




Volumn 172, Issue 5, 1994, Pages 271-280

Terbutaline in COPD comparison between turbuhaler® and chlorofluorocarbon (CFC) inhaler

Author keywords

COPD; Irreversible airway obstruction; Residual volume; Terbutaline; Volume response

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHLOROFLUOROCARBON; CORTICOSTEROID; IPRATROPIUM BROMIDE; PLACEBO; TERBUTALINE; THEOPHYLLINE;

EID: 0028100650     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/BF00164309     Document Type: Article
Times cited : (13)

References (10)
  • 1
    • 0023567409 scopus 로고
    • Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma
    • American Thoracic Society
    • (1987) Am Rev Respir Dis , vol.136 , pp. 225-244
  • 4
    • 0022359956 scopus 로고
    • The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trials: Influence of clinical diagnosis, spirometric and anthropometric variables
    • (1985) Am Rev Respir Dis , vol.132 , pp. 858-864
    • Eliasson, O.1    De Graff, A.C.2
  • 6
    • 84936658444 scopus 로고    scopus 로고
    • International Consensus Report on Diagnosis and Management of Asthma Bethesda MD: National Heart, Lung and Blood Institute (1992) US Dept of Health and Human Services publication 92-3091
  • 9
    • 0016255582 scopus 로고
    • Criteria for the assessment of reversibility in airways obstruction
    • Report of the committee on emphysema (American College of Chest Physician, G. Snider Chairman)
    • (1974) Chest , vol.65 , pp. 552-553
  • 10
    • 0024062977 scopus 로고
    • A new powder inhaler for administration of drugs to the airways
    • (1988) Pharm Res , vol.5 , Issue.8 , pp. 506-508
    • Wetterlin, K.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.